Key facts
- Notable investors include Jiangsu Jinqiao Private Equity Fund Management, Tenyall Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Beijing Jieyuan Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Beijing Jieyuan Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beijing Jieyuan Technology
Provider of advanced microscopy services intended for structural biology research. The company offers sample preparation workflows, imaging optimization, and data analysis capabilities, enabling research institutions and laboratories to conduct high-resolution molecular investigations, improve reproducibility of experimental results, accelerate structural characterization of complex biomolecules, and support broader applications in life sciences and pharmaceutical development through enhanced imaging precision and analytical depth.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Beijing Jieyuan Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beijing Jieyuan Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beijing Jieyuan Technology in its N-PORT filings yet. We sweep new filings monthly.